Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Lovat

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Biomedicines|November 27, 2021
Editorial to the Special Issue "MicroRNA in Solid Tumor and Hematological Diseases"Francesca Lovat
International Journal of Molecular Sciences|August 23, 2013
Non-coding RNAs and cancerFederica Calore, Francesca Lovat, Michela Garofalo
Seminars in Oncology|November 16, 2011
MicroRNAs in the pathogenesis of cancerFrancesca Lovat, Nicola Valeri, Carlo M Croce
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2014
Generation of mouse lines conditionally over-expressing microRNA using the Rosa26-Lox-Stop-Lox systemClaudia Piovan, Foued Amari, Francesca Lovat, et al.
Journal of Extracellular Vesicles|October 30, 2025
Exploring the Spatial Limits of Extracellular Vesicles-Mediated Intercellular CommunicationFederico Colombo, Kartik Nimkar, Erienne Grace Norton, et al.
Plos One|March 23, 2011
Role of T198 modification in the regulation of p27(Kip1) protein stability and functionMonica Schiappacassi, Sara Lovisa, Francesca Lovat, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic miceSukhinder K Sandhu, Matteo Fassan, Stefano Volinia, et al.
The Journal of Biological Chemistry|August 6, 2014
miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lungMohammad Rahman, Francesca Lovat, Giulia Romano, et al.
Oncotarget|July 1, 2016
Lung cancer exosomes as drivers of epithelial mesenchymal transitionMohammad A Rahman, Jennifer F Barger, Francesca Lovat, et al.
Signal Transduction and Targeted Therapy|January 26, 2023
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistanceGian Luca Rampioni Vinciguerra, Marina Capece, Rosario Distefano, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Biomedicines|November 27, 2021
Editorial to the Special Issue "MicroRNA in Solid Tumor and Hematological Diseases"Francesca Lovat
International Journal of Molecular Sciences|August 23, 2013
Non-coding RNAs and cancerFederica Calore, Francesca Lovat, Michela Garofalo
Seminars in Oncology|November 16, 2011
MicroRNAs in the pathogenesis of cancerFrancesca Lovat, Nicola Valeri, Carlo M Croce
Methods in Molecular Biology (Clifton, N.J.)|July 28, 2014
Generation of mouse lines conditionally over-expressing microRNA using the Rosa26-Lox-Stop-Lox systemClaudia Piovan, Foued Amari, Francesca Lovat, et al.
Journal of Extracellular Vesicles|October 30, 2025
Exploring the Spatial Limits of Extracellular Vesicles-Mediated Intercellular CommunicationFederico Colombo, Kartik Nimkar, Erienne Grace Norton, et al.
Plos One|March 23, 2011
Role of T198 modification in the regulation of p27(Kip1) protein stability and functionMonica Schiappacassi, Sara Lovisa, Francesca Lovat, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic miceSukhinder K Sandhu, Matteo Fassan, Stefano Volinia, et al.
The Journal of Biological Chemistry|August 6, 2014
miR-15b/16-2 regulates factors that promote p53 phosphorylation and augments the DNA damage response following radiation in the lungMohammad Rahman, Francesca Lovat, Giulia Romano, et al.
Oncotarget|July 1, 2016
Lung cancer exosomes as drivers of epithelial mesenchymal transitionMohammad A Rahman, Jennifer F Barger, Francesca Lovat, et al.
Signal Transduction and Targeted Therapy|January 26, 2023
Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistanceGian Luca Rampioni Vinciguerra, Marina Capece, Rosario Distefano, et al.
Pageof 6